EndoFLIP for Hiatal Hernia and Acid Reflux
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new surgical tool called EndoFLIP for individuals with acid reflux or a hiatal hernia who haven't improved with medication. The goal is to determine if measurements taken during surgery with this tool can predict the surgery's impact on daily life. It may suit those with persistent heartburn or hiatal hernia symptoms considering surgery. As an unphased trial, this study offers a unique opportunity to contribute to innovative surgical advancements and potentially enhance quality of life.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the EndoFLIP device is safe for use in surgery?
Research has shown that EndoFLIP is a tool used during surgery to assist doctors in making decisions for conditions like reflux disease and hiatal hernia. Although specific safety data is not available, EndoFLIP evaluates and guides treatments for esophageal issues, suggesting it is generally considered safe for clinical use.
EndoFLIP improves surgical outcomes by providing surgeons with more precise information. While specific data on side effects is lacking, its role in guiding surgical decisions indicates confidence in its safety. This tool measures factors like esophageal tightness, aiding doctors in making better choices during surgery.
In summary, despite the absence of direct safety data, EndoFLIP enhances surgical accuracy, implying trust in its safety during operations.12345Why are researchers excited about this trial?
Researchers are excited about EndoFLIP for hiatal hernia and acid reflux because it offers a novel approach to understanding and managing these conditions. Unlike standard treatments that often involve medications like proton pump inhibitors or surgical procedures, EndoFLIP provides real-time measurements of the esophagus and stomach junction during surgery. This innovative technology allows for precise mapping and assessment of the area, potentially leading to more effective and personalized treatment decisions. The ability to gather detailed intraoperative data could revolutionize how hiatal hernias and acid reflux are treated, optimizing outcomes and reducing the need for more invasive interventions.
What evidence suggests that the EndoFLIP is effective for hiatal hernia and acid reflux?
Research has shown that using EndoFLIP during surgery for acid reflux and hiatal hernia can greatly improve symptoms. For instance, one study found that patients reported better outcomes after antireflux surgery with EndoFLIP. Another study demonstrated that the Reflux Symptom Index, which measures reflux severity, dropped from 26 to 15 points after using similar surgical tools, indicating a return to more normal reflux levels. These findings suggest that EndoFLIP, which participants in this trial will receive, may enhance the effectiveness of surgeries for these conditions.678910
Who Is on the Research Team?
Wiley Chung, MD MHPE
Principal Investigator
Queen's University
Are You a Good Fit for This Trial?
This trial is for adults being evaluated for GERD (heartburn) or symptomatic hiatal hernia who are planning to have fundoplication surgery. It's not open to those who've had previous surgeries like hiatal hernia repair, fundoplication, esophagectomy, or gastrectomy, or can't consent.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative Workup
Participants undergo esophagogastroduodenoscopy (EGD) and EndoFLIP readings are taken
Surgery
Participants undergo fundoplication surgery with intraoperative EndoFLIP measurements
Post-operative Follow-up
Participants are monitored for post-operative symptoms and quality of life using GERD health-related quality of life score
What Are the Treatments Tested in This Trial?
Interventions
- EndoFLIP
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dr. Wiley Chung
Lead Sponsor
Dr. Wiley Chung
Lead Sponsor
Medtronic
Industry Sponsor
Geoff Martha
Medtronic
Chief Executive Officer since 2020
Finance degree from Penn State University
Dr. Richard Kuntz
Medtronic
Chief Medical Officer since 2023
MD, MSc